Mary E. Irwin

588 total citations
11 papers, 457 citations indexed

About

Mary E. Irwin is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Mary E. Irwin has authored 11 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Hematology and 2 papers in Genetics. Recurrent topics in Mary E. Irwin's work include Acute Myeloid Leukemia Research (4 papers), Genomics, phytochemicals, and oxidative stress (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Mary E. Irwin is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Genomics, phytochemicals, and oxidative stress (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Mary E. Irwin collaborates with scholars based in United States. Mary E. Irwin's co-authors include Joya Chandra, Julie L. Boerner, Natacha Bohin, Yubin Ge, Kelly L. Mueller, Melissa Singh, Hesham M. Amin, Yin Gao, Blake Johnson and Tiewei Cheng and has published in prestigious journals such as Blood, PLoS ONE and Cancer.

In The Last Decade

Mary E. Irwin

11 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary E. Irwin United States 9 287 115 88 75 60 11 457
Enrique Poradosu United States 10 308 1.1× 135 1.2× 39 0.4× 80 1.1× 29 0.5× 17 556
Lata Chauhan United States 8 313 1.1× 159 1.4× 57 0.6× 116 1.5× 22 0.4× 15 489
Martine B.W. Prinsen Netherlands 11 270 0.9× 151 1.3× 65 0.7× 36 0.5× 80 1.3× 19 456
Rempei Yanagawa Japan 7 328 1.1× 180 1.6× 90 1.0× 30 0.4× 45 0.8× 8 537
Xiangjie Lin China 11 213 0.7× 70 0.6× 55 0.6× 66 0.9× 30 0.5× 31 396
Daniel D. VonHoff United States 10 366 1.3× 205 1.8× 58 0.7× 52 0.7× 89 1.5× 13 654
Irene Filippi Italy 15 252 0.9× 102 0.9× 129 1.5× 52 0.7× 35 0.6× 29 618
Margaret H.L. Ng Hong Kong 16 399 1.4× 167 1.5× 150 1.7× 112 1.5× 53 0.9× 23 762
Natalie E. Simpson United States 14 376 1.3× 169 1.5× 123 1.4× 58 0.8× 33 0.6× 19 649
S.H. Rosenberg United States 8 356 1.2× 182 1.6× 60 0.7× 140 1.9× 33 0.6× 12 588

Countries citing papers authored by Mary E. Irwin

Since Specialization
Citations

This map shows the geographic impact of Mary E. Irwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary E. Irwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary E. Irwin more than expected).

Fields of papers citing papers by Mary E. Irwin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary E. Irwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary E. Irwin. The network helps show where Mary E. Irwin may publish in the future.

Co-authorship network of co-authors of Mary E. Irwin

This figure shows the co-authorship network connecting the top 25 collaborators of Mary E. Irwin. A scholar is included among the top collaborators of Mary E. Irwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary E. Irwin. Mary E. Irwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Irwin, Mary E., Shelley M. Herbrich, Tiewei Cheng, et al.. (2022). Targeting the NRF2/HO-1 Antioxidant Pathway in FLT3-ITD-Positive AML Enhances Therapy Efficacy. Antioxidants. 11(4). 717–717. 25 indexed citations
2.
Cheng, Tiewei, et al.. (2018). Combinatorial effects of histone deacetylase inhibitors (HDACi), vorinostat and entinostat, and adaphostin are characterized by distinct redox alterations. Cancer Chemotherapy and Pharmacology. 81(3). 483–495. 8 indexed citations
4.
Irwin, Mary E., et al.. (2015). A NOX2/Egr-1/Fyn pathway delineates new targets for TKI-resistant malignancies. Oncotarget. 6(27). 23631–23646. 23 indexed citations
5.
Irwin, Mary E., Laura D. Nelson, Claudia P. Miller, et al.. (2013). Small Molecule ErbB Inhibitors Decrease Proliferative Signaling and Promote Apoptosis in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia. PLoS ONE. 8(8). e70608–e70608. 18 indexed citations
6.
Singh, Melissa, Adrienne Howard, Mary E. Irwin, et al.. (2012). Expression and Activity of Fyn Mediate Proliferation and Blastic Features of Chronic Myelogenous Leukemia. PLoS ONE. 7(12). e51611–e51611. 22 indexed citations
7.
Irwin, Mary E., et al.. (2012). Redox Control of Leukemia: From Molecular Mechanisms to Therapeutic Opportunities. Antioxidants and Redox Signaling. 18(11). 1349–1383. 111 indexed citations
8.
Irwin, Mary E., Natacha Bohin, & Julie L. Boerner. (2011). Src family kinases mediate epidermal growth factor receptor signaling from lipid rafts in breast cancer cells. Cancer Biology & Therapy. 12(8). 718–726. 67 indexed citations
9.
Singh, Melissa, Mary E. Irwin, Yin Gao, et al.. (2011). Inhibition of the NADPH oxidase regulates heme oxygenase 1 expression in chronic myeloid leukemia. Cancer. 118(13). 3433–3445. 22 indexed citations
10.
Irwin, Mary E., Kelly L. Mueller, Natacha Bohin, Yubin Ge, & Julie L. Boerner. (2010). Lipid raft localization of EGFR alters the response of cancer cells to the EGFR tyrosine kinase inhibitor gefitinib. Journal of Cellular Physiology. 226(9). 2316–2328. 144 indexed citations
11.
Irwin, Mary E.. (2009). The Impact of Race and Neighborhood on Child Maltreatment: A Multi-Level Discrete Time Hazard Analysis. OhioLink ETD Center (Ohio Library and Information Network). 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026